Andres Francesch
Head of Department
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Andres Francesch is the Head of Department at PharmaMar SA in Spain. His research focuses on the isolation and synthesis of cyclic depsipeptides, the development of cytotoxic cyclolignans, and the metabolic disposition of novel antineoplastic agents. He has published recent articles exploring advanced methodologies in drug metabolism and the optimization of therapeutic compounds.
Articles (6)
Podophyllotoxin, a cyclolignan natural product, has been the object of extensive chemomodulation to obtain better chemotherapeutic agents. Among the obtained podophyllotoxin derivatives, podophyllic aldehyde showed very interesting potency and selectivity against several tumoral cell lines, so it became our lead compound for further modifications, as described in this work, oriented toward the enlargement of the cyclolignan skeleton. Thus, modifications performed at the aldehyde function included nucleophilic addition reactions and the incorporation of the aldehyde carbon into several five-membered rings, such as thiazolidinones and benzo-fused azoles. The synthesized derivatives were evaluated against several types of cancer cells, and although some compounds were cytotoxic at the nanomolar range, most of them were less potent and less selective than the parent compound podophyllic aldehyde, with the most potent being those having the lactone ring of podophyllotoxin. In silico ADME evaluation predicted good druggability for most of them. The results indicate that the γ-lactone ring is important for potency, while the α,β-unsaturated aldehyde is necessary to induce selectivity in these cyclolignans.
Year:
2024
Year:
2024
Year:
2023
Year:
2022
Year:
2021
Year:
2020
Collaborators (3)
Mª Ángeles Castro
Universidad de Salamanca
Arturo San Feliciano
1- Prof. Ayudante, Prof. Adjunto Contratado, Prof. Agregado interino, 1978-09-23 a 2017-09-30: 2- Prof. Agregado (Q. Orgánica), Catedrático (Q. Farmacéutica)
-
Roberto de la Torre-Martinez
Karolinska Institutet
Make your next move.
Prepare your application
Review drafts before you send them.